metformin and rg7388

metformin has been researched along with rg7388 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, Y; Rong, F; Zhou, J	1

Other Studies

1 other study(ies) available for metformin and rg7388

Article	Year
Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway. Biochemical and biophysical research communications, 2020, 12-17, Volume: 533, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Humans; MAP Kinase Signaling System; Metformin; Mice, Nude; Ovarian Neoplasms; para-Aminobenzoates; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrrolidines; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2020

Article

Year

Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway.

Biochemical and biophysical research communications, 2020, 12-17, Volume: 533, Issue:4

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Humans; MAP Kinase Signaling System; Metformin; Mice, Nude; Ovarian Neoplasms; para-Aminobenzoates; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrrolidines; Reactive Oxygen Species; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2020